Injectable Cement Market Report 2026

Injectable Cement Market Overview

• Injectable Cement market size has reached to $1.55 billion in 2025 • Expected to grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Role Of Injectable Cement In Managing Increasing Sports Injury Rates • Market Trend: Antibiotic-Loaded Bone Cement For Infection Prevention And Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Injectable Cement Market?

Injectable cement is a type of bone cement used in various orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is designed to be injected into a targeted body area, often under imaging guidance, allowing for precise placement and minimal invasiveness. Injectable cements are valued for providing immediate stabilization, facilitating minimally invasive procedures, and improving patient outcomes in orthopedic care. The main types of injectable cement include high-viscosity cement, low-viscosity cement, and medium-viscosity cement. High-viscosity cement has a thicker consistency, which makes it less fluid but provides better stability once it hardens, making it ideal for situations requiring a strong, durable fixation, such as high-stress fractures or complex joint replacements. The applications are categorized into types such as periprosthetic fractures, pelvic fractures, and others, and end users include hospitals, clinics, and others.

What Is The Injectable Cement Market Growth Forecast?

The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in injectable cement formulations, rising demand for minimally invasive surgeries, increasing orthopedic trauma cases, growth in outpatient and clinic-based procedures, higher focus on biocompatible and bioactive materials. Major trends in the forecast period include rising adoption of minimally invasive orthopedic procedures, growing use of injectable cement in fracture stabilization, increasing preference for image-guided cement injection, advancements in bioactive and composite injectable cements, improved focus on faster recovery and patient outcomes.

Global Injectable Cement Market Segmentation

1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement 2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications 3) By End User: Hospital, Clinics, Other End Users Subsegments: 1) By High Viscosity Cement: Calcium Phosphate Cements, Polymethyl Methacrylate (PMMA) Cements 2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements 3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements

What Is The Driver Of The Injectable Cement Market?

The increasing number of sports-related injuries is expected to propel the growth of the injectable cement market going forward. Sports-related injuries are physical damages sustained during athletic activities, including strains, sprains, fractures, and concussions, often requiring medical attention and rehabilitation for recovery. The rise in sports-related injuries is likely attributed to increased participation in athletic activities, more intense training regimens, and advancements in sports equipment that push physical limits, leading to higher injury rates among athletes worldwide. Injectable cement is used to treat sports-related injuries to stabilize fractures, support bone healing, and enhance surgical outcomes by providing a reliable and minimally invasive solution for bone reinforcement. For instance, July 2025, according to the Australian Institute of Health and Welfare a Australia-based government agency, cycling recorded the largest share of sports-related hospitalisations in 2023–24, representing 12% (around 7,500 cases). This was followed by Australian rules football at 8.7% (about 5,400 cases) and soccer at 8.6% (roughly 5,300 cases). Therefore, increasing sports-related injuries will drive the growth of the injectable cement industry.

Key Players In The Global Injectable Cement Market

Major companies operating in the injectable cement market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc, Exactech Inc, Spine Wave Inc, Tecres SpA, Heraeus Medical GmbH, TEKNIMED, Graftys SA, Solco Biomedical, Terumo Corporation, Bonesupport AB, Peregrine Biologics, aap Implantate AG, Biometrix Ltd, OSARTIS GmbH, IZI Medical

Global Injectable Cement Market Trends and Insights

Major companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more effective and targeted treatment during orthopedic surgeries. Antibiotic-loaded bone cement is a type of bone cement that contains antibiotics mixed into the cement material to help prevent or treat infections at the surgical site, particularly in orthopedic procedures. For instance, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement. It is the first product from the company to be certified under the MDR. COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly associated with prosthetic joint infections.

What Are Latest Mergers And Acquisitions In The Injectable Cement Market?

In September 2023, Globus Medical Inc., a US-based provider of musculoskeletal solutions, including orthopedic cement, merged with NuVasive Inc. for an undisclosed amount. This merger aims to strengthen its position in spinal surgery technologies, enhance its ability to deliver innovative, minimally invasive solutions, and drive growth in the market. NuVasive Inc. is a US-based medical device company that offers spinal treatment solutions, including injectable bone cement.

Regional Outlook

North America was the largest region in the injectable cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Injectable Cement Market?

The injectable cement market consists of sales of antibiotic-loaded bone cements, calcium phosphate cements, customizable injectable cement, and bioactive glass cement. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.